Multiple roles for IL-12 in a model of acute septic peritonitis

Journal of Immunology

Volumn 162, Issue 9, 1999, Pages 5437-5443

  Steinhauser, Matthew L ^a   Hogaboam, Cory M ^a   Lukacs, Nickolas W ^a   Strieter, Robert M ^a   Kunkel, Steven L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL PERITONITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HISTOPATHOLOGY; MORTALITY; MOUSE; NONHUMAN; PERITONEAL FLUID; PRIORITY JOURNAL; SURVIVAL;

ACUTE DISEASE; ANIMALS; CECAL DISEASES; CILASTATIN; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; FEMALE; FIBROSIS; IMIPENEM; IMMUNE SERA; IMMUNIZATION, PASSIVE; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTESTINAL PERFORATION; LIGATION; MICE; PERITONEUM; PERITONITIS; SEPSIS; WOUND HEALING;

EID: 0033136310     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Bone, R. C., R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein, W. A. Knaus, R. M. H. Schein, and W. J. Sibbald. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644.
2. Parrillo, J. E., M. M. Parker, C. Natanson, A. F. Suffredini, R. L. Danner, R. E. Cunnion, and F. P. Ognibene. 1990. Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann. Intern. Med. 113:227.
3. Holzheimer, R. G., K. H. Muhrer, N. L'Allemand, T. Schmidt, and K. Henneking. 1991. Intraabdominal infections: classification, mortality, scoring and pathophysiology. Infection 19:447.
4. Remick, D., R. Strieter, M. Eskandari, D. T. Nguyen, M. A. Genord, C. L. Raiford, and S. L. Kunkel. 1990. Role of tumor necrosis factor-α in lipopolysaccharide-induced pathologic alterations. Am. J. Pathol. 136:49.
5. Brunda, M. 1994. Interleukin-12. J. Leukocyte Biol. 55:280.
6. Wagner, R. D., H. Steinberg, J. F. Brown, and C. J. Czuprynski. 1994. Recombinant interleukin-12 enhances resistance in mice to Listeria monocytogenes infection. Microb. Pathog. 17:175.
7. Flynn, J., N. Goldstein, K. Triebold, J. Sypek, S. Wolf, and B. Bloom. 1995. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis. J. Immunol. 155:2515.
8. Greenberger, M. J., S. L. Kunkel, R. M. Strieter, N. Lukacs, J. Bramson, J. Gauldie, F. Graham, M. Hitt, J. Danforth, and T. J. Standiford. 1996. IL-12 gene therapy protects mice in lethal Klebsiella pneumoniae. J. Immunol. 157:3006.
9. Metzger, D., R. Raeder, V. Van Cleave, and M. Boyle. 1995. Protection of mice from group A streptococcal skin infection by interleukin-12. J. Infect. Dis. 171:1643.
10. Kincy-Cain, T., J. Clements, and K. Bost. 1996. Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublin. Infect. Immun. 64:1437.
11. Heinzel, F., R. Rerko, P. Ling, J. Hakini, and D. Schoenhaut. 1994. Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of γ interferon. Infect. Immun. 62:4244.
12. Bone, R. 1991. The pathogenesis of sepsis. Ann. Intern. Med. 115.
13. Standiford, T. J., R. M. Strieter, N. W. Lukacs, and S. L. Kunkel. 1995. Neutralization of IL-10 increases lethality in endotoxemia: cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J. Immunol. 155:2222.
14. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815.
15. Smith, S. R., C. Terminelli, L. Kenworthy-Bott, A. Calzetta, and J. Donkin. 1994. The cooperative effects of TNF-α and IFN-γ are determining factors in the ability of IL-10 to protect mice from lethal endotoxemia. J. Leukocyte Biol. 55:711.
16. Gerard, C., C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu. 1993. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:547.
17. Walley, K. R., N. W. Lukacs, T. J. Standiford, R. M. Strieter, and S. L. Kunkel. 1996. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect. Immun. 64:4733.
18. Wysocka, M., M. Kubin, L. Q. Vieira, L. Ozmen, G. Garotta, P. Scott, and G. Trinchieri. 1995. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25:672.
19. Mancuso, G., C. Vitaliano, F. Genovese, M. Gambuzza, C. Beninati, and G. Teti. 1997. Role of interleukin 12 in experimental neonatal sepsis caused by group B streptococci. Infect. Immun. 65:3731.
20. Chen, Y., W. Yang, C. Ting, W. Tsai, D. Yang, J. Whang-Peng, and R. Perng. 1997. Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients. Chest 112:960.
21. Yin, Z., J. Braun, L. Neure, P. Wu, L. Liu, U. Eggens, and J. Sieper. 1997. Crucial role of interleukin-10/interleukin-12 T helper cytokine response in reactive arthritis. Arthritis Rheum. 40:1788.
22. Hogaboam, C., M. Steinhauser, H. Shock, N. Lukacs, R. Strieter, T. Standiford, and S. Kunkel. 1998. Therapeutic effects of nitric oxide inhibition during experimental fecal peritonitis: role of interleukin-10 and monocyte chemoattractant protein 1. Infect. Immun. 66:650.
23. Evanoff, H., M. Burdick, S. Moore, S. Kunkel, and R. Strieter. 1992. A sensitive ELISA for the detection of human monocyte chemoattractant protein-1 (MCP-1). Immunol. Invest. 21:39.
24. Lipman, B., and H. Neu. 1988. Imipenum: a new carbapenum antibiotic. Med. Clin. N. Am. 72:567.
25. Chehimi, J., and G. Trinchieri. 1994. Interleukin 12: a bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency. Clin. Immunol. 14:149.
26. Zisman, D., S. Kunkel, R. Strieter, J. Gauldie, W. Tsai, J. Bramson, J. Wilkowski, K. Bucknell, and T. Standiford. 1997. Anti-interteukin-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Escherichia coli peritoneal sepsis. Shock 8:349.
27. Hazelzet, J. A., R. F. Kornelisse, T. C. van der Pouw Kraan, K. F. Joosten, E. van der Voort, G. van Mierlo, M. H. Suur, W. C. Hop, R. de Groot, and C. E. Hack. 1997. Interleukin 12 levels during the initial phase of septic shock with purpura in children: relation to severity of disease. Cytokine 9:711.
28. Greenberger, M., R. M. Strieter, S. Kunkel, J. Danforth, R. Goodman, and T. Standiford. 1995. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumoniae. J. Immunol. 155:722.
29. Jenson, W., R. Rose, A. Wasserman, T. Kalb, K. Anton, and H. Remold. 1987. In vitro activation of the antibacterial activity of human pulmonary macrophages by recombinant γ Interferon. J. Infect. Dis. 155:574.
30. Mattner, F., L. Ozmen, F. J. Podlaski, V. L. Wilkinson, D. H. Presky, M. K. Gately, and G. Alber. 1997. Treatment with homodimeric interleukin-12 (IL-12) p40 protects mice from IL-12-dependent shock but not from tumor necrosis factor α-dependent shock. Infect. Immun. 65:4734.
31. Heinzel, F., D. Schoenhaut, R. Rerko, and M. Gately. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505.
32. Wickel, D. J., W. G. Cheadle, M. A. Mercer-Jones, and R. N. Garrison. 1997. Poor outcome from peritonitis is caused by disease acuity and organ failure, not recurrent peritoneal infection. Ann. Surg. 225:744.
33. Hensler, T., C. Heidecke, H. Hecker, H. Bartels, N. Zantl, H. Wagner, J. Siewert, and B. Holzmann. 1998. Increased susceptibility to postoperative sepsis in patients with impaired monocyte IL-12 production. J. Immunol. 161:2655.
34. Gazzinelli, R. T., T. S. Hieny, T. A. Wynn, S. Wolf, and A. Sher. 1993. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon-γ by an intracellular parasite and induces resistance in T-cell deficient hosts. Proc. Natl. Acad. Sci. USA 90:6115.
35. Howard, M., T. Muchamuel, S. Andrade, and S. Menon. 1993. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1205.
36. van der Poll, T., A. Marchant, W. Buurman, L. Berman, C. Keogh, D. Lazarus, L. Nguyen, M. Goldman, L. Moldawer, and S. Lowry. 1995. Endogenous IL-10 protects mice from death during septic peritonitis. J. Immunol. 155:5397.
37. Cassatella, M., L. Meda, S. Bonora, M. Ceska, and G. Constantin. 1993. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes: evidence for an autocrine role of tumor necrosis factor and IL-Ib in mediating the production of IL-8 triggered by lipopolysaccharide. J. Exp. Med. 178:2207.
38. Kasama, T., R. M. Strieter, N. W. Lukacs, M. D. Burdick, and S. L. Kunkel. 1994. Regulation of neutrophil-derived chemokine expression by IL-10. J. Immunol. 152:3559.
39. Sawa, T., D. Corry, M. Gropper, M. Ohara, K. Kurahashi, and J. Wiener-Kronish. 1997. IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. J. Immunol. 159:2858.
40. Van der Poll, T., A. Marchant, C. Keogh, M. Goldman, and S. Lowry. 1996. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J. Infect. Dis. 174:994.
41. de Vries, J. E. 1995. Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann. Med. 27:537.
42. Sartor, R. B. 1995. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol. Clin. North. Am. 24:475.
43. Kirsner, R., and W. Eaglstein. 1993. The wound healing process. Dermatol. Clin 11:629.
44. Narayanan, A., R. Page, and J. Swanson. 1989. Collagen synthesis by human fibroblasts: regulation by transforming growth factor-β in the presence of other inflammatory mediators. Biochem. J. 260:463.
45. Miles, R., T. Paxton, D. Zacheis, D. Dries, and R. Gamelli. 1994. Systemic administration of interferon-γ impairs wound healing. J. Surg. Res. 56:288.
46. Gurujeyalakshmi, G., and S. N. Giri. 1995. Molecular mechanisms of antifibrotic effect of Interferon γ in bleomycin-mouse model of lung fibrosis: downregulation of TGF-β and procollagen I and III gene expression. Exp. Lung Res. 21:791.